Campbell & Co Investment Adviser’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,495
Closed -$804K 1351
2025
Q2
$804K Buy
+33,495
New +$777K 0.05% 598
2024
Q2
Sell
-8,964
Closed -$270K 1306
2024
Q1
$270K Sell
8,964
-4,662
-34% -$129K 0.02% 944
2023
Q4
$390K Sell
13,626
-39,115
-74% -$1.15M 0.04% 821
2023
Q3
$1.95M Buy
52,741
+5,163
+11% +$197K 0.23% 94
2023
Q2
$1.86M Buy
+47,578
New +$1.86M 0.33% 33

Other funds holding RTO

Campbell & Co Investment Adviser's RTO Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Rentokil (RTO) in Q3 2025, closing a stake of 33,495 shares — an estimated $804K sold.

Campbell & Co Investment Adviser first reported a position in RTO in Q2 2023 and held it in 5 quarters. The position peaked at $1.95M in Q3 2023. 213 funds tracked by Wall St. Rank hold RTO as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Rentokil position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 33,495 Rentokil shares in Q3 2025, an estimated $804K.
  • Campbell & Co Investment Adviser first reported a position in Rentokil in Q2 2023 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's Rentokil position peaked at $1.95M in Q3 2023.
  • 213 funds tracked by Wall St. Rank held Rentokil as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.